Inhibition of herpes simplex virus by polyamines

Antiviral Chemistry and Chemotherapy

Volumn 20, Issue 2, 2009, Pages 87-98

  Yudovin Farber, Ira ^a   Gurt, Irina ^a   Hope, Ronen ^a   Domb, Abraham J ^a   Katz, Ehud ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DEXTRAN PROPAN 1,3 DIAMINE; DEXTRAN SPERMINE; POLYAMINE DERIVATIVE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STRUCTURE ACTIVITY RELATION; VIRION; VIROGENESIS; VIRUS CELL INTERACTION;

CELL LINE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; POLYAMINES; SIMPLEXVIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS INTERNALIZATION;

EID: 70449380086     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1401     Document Type: Article

References (35)

1. Arduino PG, Porter SR. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management. Oral Dis 2006; 12:254-270.
2. Leone P. Reducing the risk of transmitting genital herpes: advances in understanding and therapy. Curr Med Res Opin 2005; 21:1577-1582.
3. Kolokotronis A, Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin Microbiol Infect 2006; 12:202-211.
4. Labetoulle M. The latest in herpes simplex keratitis therapy. J Francais D'ophtal 2004; 27:547-557.
5. Dekonenko EP, Lebedev AV. Herpetic encephalitis with mental disorders. Zh Neurol Psikhiatr Im S S Korsakova 1997; 97:87-90.
6. Wetzel S, Wollenberg A. Eczema herpeticatum. Hautarzt 2004; 55:646-652.
7. Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Res 2004; 61:73-81.
8. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003; 16:114-128.
9. Laiskonis A, Thune T, Neldam S, Hiltunen-Back E. Valacyclovir in the treatment of facial herpes simplex virus infection. J Infect Dis 2002; 186:S66-S70.
10. Gazzard BG, Barton SE. Therapy for herpes-simplex virus with emphasis on the role of foscarnet. Curr Opin Infect Dis 1993; 6:773-77;
11. Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol 2003; 26:29-37.
12. Schmid-Wendtner MH, Korting HC. Penciclovir cream-improved topical treatment for herpes simplex infections. Skin Pharmacol Physiol 2004; 17:214-218.
13. Yeung-Yue KA, Brentjens MH, Lee PC, Tyring SK. The management of herpes simplex virus infections. Curr Opin Infect Dis 2002; 15:115-122.
14. Langeland N, Holmsen H, Lillehaug JR, Haarr L. Evidence that neomycin inhibits binding of herpes-simplex virus type-1 to the cellular receptor- J Virol 1987; 61:3388-3393.
15. Langeland N, Moore LJ, Holmesen H, Haarr L. Interaction of polylysine with the cellular receptor for herpes simplex virus type 1. J Gen Virol 1988; 69:1137-1145.
16. Burger WC, Stahmann MA. Combination of lysine polypetides with tobacco mosaic virus. J Biol Chem 1951; 193:13-22.
17. Docherty JJ, Pollock JJ. Inactivation of herpes-simplex virus type-1 and type-2 by synthetic histidine peptides. Antimicrob Agents Chemother 1987; 31:1562-1566.
18. Azzam T, Raskin A, Makovitzki A, et al. Cationic polysaccharides for gene delivery. Macromolecules 2002; 35:9947-9953.
19. Berscht PC, Nies B, Liebendorfer A, Kreuter J. In-vitro evaluation of biocompatibility of different wound dressing materials. J Mater Sci Mater Med 1995; 6:201-205.
20. Carreno-Gomez B, Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int J Pharm 1997; 148:231-240.
21. Yudovin-Farber I, Azzam T, Metzer E, Taraboulos A, Domb AJ. Cationic polysaccharides as antiprion agents. J Med Chem 2005; 48:1414-1420.
22. Kumar N, Azzam T, Domb AJ. Molecular mass distribution of polycations and dextrans by high-performance size exclusion chromatography. Polymers for Advanced Technologies 2002; 13:1071-1077.
23. Azzam T, Eliyahu H, Shapira L, et al. Polysaccharideoligoamine based conjugates for gene delivery. J Med Chem 2002; 45:1817-182 4.
24. Zhao H, Heindel ND. Determination of degree of substitution of formyl groups in polyaldehyde dextran by the hydroxylamine hydrochloride method. Pharm Res 1991; 8:400-402.
25. Siiman O, Wilkinson J, Burshteyn A, Roth P, Ledis S. Fluorescent neoglycoproteins antibody-aminodextran-phycobiliprotein conjugates. Bioconjug Chem 1999; 10:1090-1106.
26. Mosmann T. Rapid colorimetric assay for cellular growth and survival - application to proliferation and cyto-toxicity assays. J Immunol Methods 1983; 65:55-63.
27. Denizot F, Lang R. Rapid colorimetric assay for cell-growth and survival - modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89:271-277.
28. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell-growth cell kill. J Immunol Methods 1989; 119:203-210.
29. Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium bromide (Mtt) - subcellular-localization, substrate dependence, and involvement of mitochondrial electron-transport in Mtt reduction. Arch Biochem Biophys 1993; 303:474-482.
30. Ifrah M, Stienlauf S, Shoresh M, Katz E. A tetrazolium-based colorimetric assay for titration of neutralizing antibodies against vaccinia virus. Viral Immunol 1998; 11:49-54.
31. Wudunn D, Spear PG. Initial interaction of herpes-simplex virus with cells is binding to heparan-sulfate. J Virol 1989; 63:52-58.
32. Trybala E, Liljeqvist JA, Svennerholm B, Bergstrom T. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J Virol 2000; 74:9106-9114.
33. Campadelli-Fiume G, Stirpe D, Boscaro A, et al. Glycoprotein C-dependent attachment of herpes-simplex virus to susceptible cells leading to productive infection. Virology 1990; 178:213-222.
34. Langeland N, Oyan AM, Marsden HS, et al. Localization on the herpes-simplex virus type-1 genome of a region encoding proteins involved in adsorption to the cellular receptor. J Virol 1990; 64:1271-1277.
35. Oyan AM, Dolter KE, Langeland N, et al. Resistance of herpes-simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein-C. J Virol 1993; 67:2434-2441.